phase clinic trial floxuridin high-dos continu infus leucovorin calcium sixty-two patient metastat diseas continu infus folin acid leucovorin calcium Lv floxuridin fudr Lv constant intraven IV infus day fudr IV push day PM dose program dose-limit toxic diarrhea stomat hematolog toxic minim eighty-two percent assess patient chemotherapi regimen complet remiss month partial remiss month patient popul overal respons rate data combin therapi Lv fudr clinic use patient sensit drug combin dose fudr initi therapi cycl day subsequ escal patient extrem sensit phase II studi progress dose 